文献速递特殊人群用药治疗药物监测与药物基因组学

个体化医学在糖尿病管理中的应用

Using Personalized Medicine in the Management of Diabetes Mellitus.
PubMed 文献 · Pharmacotherapy · 2017-08-15

本文综述了药物基因组学证据在常见口服降糖药及多基因和单基因糖尿病管理中的应用。证据支持在青年单基因糖尿病治疗中使用基因检测和个体化方法,但对多基因2型糖尿病的药物遗传学应用数据尚不充分,仅提示未来应用方向。

要点

  • 青年单基因糖尿病治疗有证据支持基因检测和个体化方法。
  • 多基因2型糖尿病的药物遗传学应用数据尚不充分。
  • 个体风险和对口服降糖药反应的变异性已被报道。

核心结论

  • 证据支持在青年单基因糖尿病治疗中使用基因检测和个体化方法。
  • 多基因2型糖尿病的药物遗传学应用数据尚不充分,但提示未来应用方向。

研究设计与样本

  • 综述了相关原始文献来源和当前基于证据的糖尿病管理指南。

主要发现

  • 个体风险和后续糖尿病发展的变异性已被报道。
  • 对当前可用多种口服降糖治疗的反应存在差异。
  • 药物基因组学研究试图揭示风险易感性和治疗反应个体变异性的可遗传成分。

临床怎么用

  • 在青年单基因糖尿病治疗中可考虑基因检测和个体化方法。
  • 多基因2型糖尿病的药物遗传学方法目前数据尚不充分。

局限性

  • 多基因2型糖尿病的药物遗传学应用数据尚不充分。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Diabetes mellitus is a worldwide problem with an immense pharmacoeconomic burden. The multifactorial and complex nature of the disease lends itself to personalized pharmacotherapeutic approaches to treatment. Variability in individual risk and subsequent development of diabetes has been reported in addition to differences in response to the many oral glucose lowering therapies currently available for diabetes pharmacotherapy. Pharmacogenomic studies have attempted to uncover the heritable components of individual variability in risk susceptibility and response to pharmacotherapy. We review the current pharmacogenomics evidence as it relates to common oral glucose lowering therapies and how they can be utilized in the management of polygenic and monogenic forms of diabetes. Evidence supports the use of genetic testing and personalized approaches to the treatment of monogenic diabetes of the young. The data are not as robust for the current application of pharmacogenetic approaches to the treatment of polygenic type 2 diabetes mellitus, but there are suggestions as to future applications in this regard. We reviewed pertinent primary literature sources as well as current evidence-based guidelines on diabetes management.

来源:Pharmacotherapy,查看原文。版权归原作者所有。

引用

  1. Elk N, Iwuchukwu OF. Using Personalized Medicine in the Management of Diabetes Mellitus. Pharmacotherapy. 2017. PMID: 28654165. doi:10.1002/phar.1976

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。